Emerging Infectious Diseases is an open-access, peer-reviewed journal published monthly by the Centers for Disease Control and Prevention (CDC). Note that beginning with Volume 26, the journal began publishing online-only. Publication in EID enables compliance with the NIH Public Access Policy.
Emerging Infectious Diseases follows the International Committee of Medical Journal Editors recommendations for the conduct, reporting, editing, and publishing of scholarly work in medical journals. The journal’s peer review process allows for critical assessment of submitted manuscripts by experts who are usually not part of its editorial staff. As an independent publication, the journal’s peer-review process operates independently from CDC’s clearance processes.
The conclusions, findings, and opinions expressed by authors contributing to Emerging Infectious Diseases do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by the Public Health Service or by the U.S. Department of Health and Human Services.
《Emerging Infectious Diseases》是一本由CENTERS DISEASE CONTROL & PREVENTION出版商出版的专业医学期刊,该刊创刊于1995年,刊期Monthly,该刊已被国际权威数据库SCI、SCIE收录。在中科院最新升级版分区表中,该刊分区信息为大类学科:医学 2区,小类学科:免疫学 2区;传染病学 2区;在JCR(Journal Citation Reports)分区等级为Q1。该刊发文范围涵盖免疫学等领域,旨在及时、准确、全面地报道国内外免疫学工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等,促进学术交流,鼓励学术创新。2021年影响因子为16.126,平均审稿速度约1.0个月。
大类学科 | 分区 | 小类学科 | 分区 | Top期刊 | 综述期刊 |
医学 | 2区 | IMMUNOLOGY 免疫学 INFECTIOUS DISEASES 传染病学 | 2区 2区 | 是 | 否 |
JCR分区等级 | JCR所属学科 | 分区 | 影响因子 |
Q1 | INFECTIOUS DISEASES | Q1 | 16.126 |
IMMUNOLOGY | Q1 |
影响因子 | h-index | Gold OA文章占比 | 研究类文章占比 | OA开放访问 | 平均审稿速度 |
16.126 | 202 | 97.35% | 98.76% | 开放 | 约1.0个月 |